Rapid Dose Therapeutics Corp. DOSE
CNSX
| 08/31/2026 | 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 6.20K | 10.60K | 8.50K | 78.10K | 6.20K |
| Total Receivables | 96.20K | 86.20K | 123.40K | 185.30K | 499.30K |
| Inventory | 69.10K | 113.00K | 117.40K | 136.90K | 150.40K |
| Prepaid Expenses | 7.40K | 25.50K | 17.70K | 28.70K | 23.50K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | 46.40K | 47.20K |
| Total Current Assets | 178.80K | 235.40K | 267.00K | 475.50K | 726.60K |
|
|
|||||
| Total Current Assets | 178.80K | 235.40K | 267.00K | 475.50K | 726.60K |
| Net Property, Plant & Equipment | 1.89M | 1.98M | 2.09M | 2.24M | 2.37M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 46.70K | 47.00K | 47.50K | -- | -- |
| Total Assets | 2.11M | 2.27M | 2.41M | 2.71M | 3.09M |
|
|
|||||
| Total Accounts Payable | 1.73M | 1.66M | 1.58M | 1.31M | 1.69M |
| Total Accrued Expenses | 2.05M | 1.86M | 1.85M | 1.68M | 1.79M |
| Short-term Debt | 2.70M | 2.62M | 2.25M | 2.74M | 2.08M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 185.40K | 178.10K | 171.90K | 168.60K | 171.50K |
| Total Finance Division Other Current Liabilities | -- | -- | 336.60K | -- | 11.40K |
| Total Other Current Liabilities | -- | -- | 336.60K | -- | 11.40K |
| Total Current Liabilities | 6.67M | 6.32M | 6.19M | 5.89M | 5.74M |
|
|
|||||
| Total Current Liabilities | 6.67M | 6.32M | 6.19M | 5.89M | 5.74M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 2.70M | 2.62M | 2.25M | 2.74M | 2.08M |
| Capital Leases | 1.35M | 1.41M | 1.48M | 1.57M | 1.64M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 8.02M | 7.73M | 7.67M | 7.47M | 7.37M |
|
|
|||||
| Common Stock & APIC | 26.37M | 26.42M | 26.61M | 25.88M | 26.04M |
| Retained Earnings | -35.55M | -35.18M | -35.19M | -33.85M | -33.59M |
| Treasury Stock & Other | 3.27M | 3.28M | 3.32M | 3.21M | 3.27M |
| Total Common Equity | -5.91M | -5.47M | -5.26M | -4.76M | -4.28M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -5.91M | -5.47M | -5.26M | -4.76M | -4.28M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -5.91M | -5.47M | -5.26M | -4.76M | -4.28M |
|
|
|||||